Envestnet Asset Management
KYNB

Envestnet Asset Management’s Kyntra Bio KYNB Stock Holding History

Envestnet Asset Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-920
Closed -$799K – 3652
2021
Q1 		$799K Buy
920
+70
+8% +$74.5K ﹤0.01% 2565
2020
Q4 		$788K Sell
850
-292
-26% -$307K ﹤0.01% 2395
2020
Q3 		$1.17M Buy
1,142
+186
+19% +$200K ﹤0.01% 1923
2020
Q2 		$969K Sell
956
-88
-8% -$81.7K ﹤0.01% 1988
2020
Q1 		$907K Buy
1,044
+208
+25% +$207K ﹤0.01% 1878
2019
Q4 		$896K Sell
836
-57
-6% -$58.2K ﹤0.01% 2094
2019
Q3 		$826K Buy
893
+35
+4% +$38.4K ﹤0.01% 2077
2019
Q2 		$969K Buy
858
+56
+7% +$61.3K ﹤0.01% 1960
2019
Q1 		$1.09M Buy
802
+615
+329% +$834K ﹤0.01% 1859
2018
Q4 		$216K Buy
+187
New +$210K ﹤0.01% 2650
2018
Q3 		– Sell
-34
Closed -$54K – 1702
2018
Q2 		$54K Buy
34
+10
+42% +$13K ﹤0.01% 2181
2018
Q1 		$27K Buy
24
+10
+71% +$13.2K ﹤0.01% 2305
2017
Q4 		$17K Sell
14
-16
-53% -$20.1K ﹤0.01% 2543
2017
Q3 		$40K Buy
+30
New +$31.6K ﹤0.01% 2339

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Envestnet Asset Management's KYNB Position: Q2 2021 in Review

Envestnet Asset Management sold out of Kyntra Bio (KYNB) in Q2 2021, closing a stake of 920 shares — an estimated $799K sold.

Envestnet Asset Management first reported a position in KYNB in Q3 2017 and held it in 14 quarters. The position peaked at $1.17M in Q3 2020. 174 funds tracked by Wall St. Rank hold KYNB as of Q2 2021.

  • Envestnet Asset Management reported no remaining Kyntra Bio position as of Q2 2021 after selling out during the quarter.
  • Envestnet Asset Management sold 920 Kyntra Bio shares in Q2 2021, an estimated $799K.
  • Envestnet Asset Management first reported a position in Kyntra Bio in Q3 2017 and held it in 14 quarters.
  • Envestnet Asset Management's Kyntra Bio position peaked at $1.17M in Q3 2020.
  • 174 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2021.

Based on Envestnet Asset Management's 13F filing for Q2 2021, filed 4 Aug 2021.